WeVote
Log In

Bill

Bill

HB 1547

Consumer Protection Act; exempt certain pharmaceutical distributors from.

2025 Regular Session Introduced by Kevin Horan

Failed bill would have exempted specific pharmaceutical distributors from Mississippi consumer protection regulations, creating potential liability gaps for patients receiving medications.

Died In Conference
#businessandcommerce #judiciary #divisiona
0
WeVote Research Nonpartisan
Bill Summary · HB 1547

Legislative bill overview

HB 1547 would have exempted certain pharmaceutical distributors from Mississippi's Consumer Protection Act, creating a carve-out for specific pharmaceutical distribution entities from consumer protection regulations. The bill died in conference committee on March 31, 2025, after disagreements between House and Senate versions could not be resolved.

Why is this important

Pharmaceutical distributors handle medications that reach patients, so exemptions from consumer protection laws could affect complaint resolution, liability standards, and recourse available to consumers experiencing problems with drug distribution. The bill's failure means Mississippi consumers retain full consumer protection rights against all pharmaceutical distributors without exception.

Potential points of contention

  • Industry vs. consumer protection balance: Exemptions benefit distributors by reducing regulatory burden and liability exposure, but may leave consumers with fewer legal protections and remedies for distribution errors or quality issues
  • Selective regulation concerns: Creating exemptions for "certain" distributors raises questions about fairness, competitive disadvantage for non-exempt competitors, and whether criteria for exemption are clearly defined
  • Public health implications: Pharmaceutical distribution directly affects medication safety and access, making exemptions potentially consequential for patient outcomes and liability for adverse events

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.